SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFY.L Regulatory News (FFY)

  • There is currently no data for FFY

Form 8.3 - [Fyffes Plc]

15 Dec 2016 14:58

RNS Number : 9971R
BNP Paribas London
15 December 2016
 

Ap19

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

Name of person dealing (Note 1)

BNP Paribas SA

Company dealt in

Fyffes Plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

Ordinary Shares

Date of dealing

13 December 2016

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

7,014,806 (2.13%)

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

7,014,806 (2.13%)

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

 

(2) Derivatives (other than options)

 

(3) Options and agreements to purchase/sell

Total

Ap20

 

 

1. DEALINGS (Note 4)

 

(a) Purchases and sales

 

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (Note 5)

Sale

40,000

EUR2.2293

Purchase

500,000

EUR2.2302

 

 

(b) Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

(c) Options transactions in respect of existing relevant securities

 

 

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

(ii) Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

Ap21

 

2. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any 

relevant securities to which any derivative referred to on this form is referenced. If none, this

should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)  NO

 

Date of disclosure

15 December 2016

Contact name

David Burfoot

Telephone number

0207 595 9695

If a connected EFM, name of offeree/offeror with which connected

If a connected EFM, state nature of connection (Note 10)

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEUVVSRNVAUAAA
Date   Source Headline
20th Dec 20125:25 pmRNSDirector/PDMR Shareholding
7th Dec 20124:03 pmRNSTrading Statement
1st Oct 20125:25 pmRNSGrant of share options
19th Sep 20122:47 pmRNSDirector/PDMR Shareholding
3rd Sep 20127:00 amRNSHalf Yearly Report
28th Aug 20127:00 amRNSHalf Yearly Report Date
23rd Jul 20124:29 pmRNSDirector Declaration
23rd Jul 20124:19 pmRNSDirectorate Change
20th Jul 20124:35 pmRNSPrice Monitoring Extension
29th Jun 20124:04 pmRNSBlocklisting Interim Review
15th Jun 201210:05 amRNSHolding(s) in Company
8th Jun 201211:14 amRNSHolding(s) in Company
6th Jun 20127:00 amRNSHolding(s) in Company
25th May 201210:09 amRNSHolding(s) in Company
10th May 20123:28 pmRNSResult of AGM
10th May 20127:00 amRNSTrading Statement
4th Apr 20125:06 pmRNSAnnual Financial Report
6th Mar 20125:08 pmRNSDirector Declaration
6th Mar 20125:01 pmRNSDirectorate Change
2nd Mar 20129:05 amRNSHolding(s) in Company
1st Mar 20127:00 amRNSFinal Results
23rd Feb 20122:53 pmRNSHolding(s) in Company
23rd Feb 20122:15 pmRNSNotice of Results
17th Jan 201212:14 pmRNSBlocklisting Interim Review
17th Jan 201211:14 amRNSTreasury Stock
30th Dec 201112:35 pmRNSPrice Monitoring Extension
21st Dec 20113:25 pmRNSDirectorate Change
16th Dec 20115:35 pmRNSDirector/PDMR Shareholding
1st Dec 20119:42 amRNSHolding(s) in Company
29th Nov 20114:40 pmRNSSecond Price Monitoring Extn
29th Nov 20114:35 pmRNSPrice Monitoring Extension
23rd Nov 20113:18 pmRNSHolding(s) in Company
18th Nov 20113:18 pmRNSHolding(s) in Company
18th Nov 20113:12 pmRNSTransaction in Own Shares
18th Nov 20119:59 amRNSHolding(s) in Company
14th Oct 20114:26 pmRNSHolding(s) in Company
14th Oct 20119:51 amRNSHolding(s) in Company
11th Oct 20113:27 pmRNSHolding(s) in Company
11th Oct 201111:59 amRNSHolding(s) in Company
10th Oct 20113:14 pmRNSHolding(s) in Company
10th Oct 201110:01 amRNSTransaction in Own Shares
26th Sep 201110:09 amRNSHolding(s) in Company
19th Sep 201110:15 amRNSTransaction in Own Shares
5th Sep 20117:00 amRNSHalf Yearly Report
30th Aug 20119:21 amRNSNotice of Results
15th Aug 201110:31 amRNSHolding(s) in Company
5th Aug 20112:44 pmRNSHolding(s) in Company
5th Aug 20119:15 amRNSHolding(s) in Company
2nd Aug 20114:51 pmRNSHolding(s) in Company
2nd Aug 201111:29 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.